The company posted a net profit of ₹1.21 crore despite revenue falling to just ₹0.63 crore, highlighting a complete reliance on non-operating income during a business transition.
Agribio Spirits reported a 23.5% year-on-year rise in net profit for Q1 FY27. This came alongside a staggering 91.4% collapse in revenue, underscoring a period where earnings were entirely supported by other income.
For Agribio Spirits, the June quarter was a story of two starkly different financial lines. The company is in the midst of a fundamental pivot from its legacy jute trading business to building an alcohol manufacturing empire. This transition left its core sales nearly absent, yet the bottom line still grew.
The numbers tell a contradictory tale. Revenue plummeted 91.4% year-on-year to just ₹0.63 crore. Sequentially, the drop was even steeper at 95.1% from the March quarter. Despite this, net profit rose 23.5% to ₹1.21 crore. The quarterly trend shows revenue volatility is the norm, while profit has held in a narrow band.
Revenue & profit
Revenue (₹ Cr)
Net Profit (₹ Cr)
Metric
CurrentQ1 FY27
PreviousQ4 FY26
Same quarter LYQ1 FY26
Revenue (₹ Cr)
0.63YoY -91%
12.95
7.36
Net Profit (₹ Cr)
1.21YoY +23%
0.90
0.98
The Engine Behind the Profit
The profit increase came entirely from non-operating sources. According to the company's filing, other income of ₹0.56 crore and a sharp 93.4% sequential drop in total expenses propped up the earnings. The operating business itself generated a loss, with MarketsMojo citing an operating profit-to-net-sales ratio of 0.00% for the quarter.
This underscores a period where the legacy jute export business has effectively stalled. The company's main revenue driver, tied to government purchases under the Jute Packaging Materials Act, saw no material sales. Meanwhile, its new alcohol ventures are not yet contributing.
Building the New Core
The future hinges on the alcohol business consolidation now underway. Research from StockScans details the plan: merging associate distiller Agribiotech Industries and ramping up the wholly-owned Solkit Distillery. The subsidiary commenced production in September 2026, just after the quarter ended.
A key milestone was reached in October, when shareholders approved the merger of Agribiotech into the listed entity. This absorption is the strategic endgame to create a single, scalable spirits company, but it remains subject to final NCLT approvals.
The market has been pricing in this potential, not the current financials. The stock hit a 52-week high of ₹349.95 in November, according to MarketsMojo. Yet, the same outlet downgraded the stock to 'Strong Sell' on November 10, citing deteriorating technicals and “flat financial performance.”
Key Points
Net profit grew 23.5% year-on-year to ₹1.21 crore, but this was entirely supported by other income as core revenue collapsed 91.4%.
The company is in a transition phase, with its legacy jute trading business dormant and the new alcohol manufacturing operations not yet contributing meaningfully to sales.
Shareholders have approved the merger of key associate Agribiotech Industries, a critical step in consolidating the future alcohol business under one listed roof.
Despite weak fundamentals, the stock has seen strong price momentum, hitting a 52-week high in November, even as analysts like MarketsMojo maintain a sell rating.
“
Hexa Perspective
The quarter reveals a company trading on promise rather than performance. The profit is a mirage, built on falling expenses and other income, while the operating engine has stalled. Investors are clearly betting on the successful integration of the alcohol assets, a process that is advancing but not yet revenue-generating.
The risk is a prolonged gap between promise and delivery. The stock's rich valuation, at a 73% premium to the industry PE, leaves little room for execution delays. The next few quarters will be decisive, showing whether the alcohol business can quickly offset the vanished jute revenue.
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.
Frequently asked questions
What were Agribio Spirits' Q1 FY27 results?
For Q1 FY27 (June 2026 quarter), Agribio Spirits reported revenue of ₹0.63 crore, a 91.4% year-on-year decline. Net profit was ₹1.21 crore, marking a 23.5% increase from the same quarter last year. The profit growth was supported by other income, not core operations.
Why did Agribio Spirits' revenue collapse by over 90% in Q1 FY27?
Agribio Spirits' revenue collapsed because its core legacy business of jute trading and exports saw minimal activity during the quarter. The company is in a transition phase, shifting its focus to alcohol manufacturing, and the new ventures are not yet contributing significant sales.
How did Agribio Spirits report higher profit despite a massive revenue drop?
Agribio Spirits reported a higher profit due to a sharp reduction in total expenses, which fell 93.4% quarter-on-quarter, and other income of ₹0.56 crore. This non-operating income and cost rationalisation offset the complete lack of profitability from its core sales activities.
What is the update on Agribio Spirits' alcohol manufacturing plans?
Agribio Spirits is consolidating its alcohol business by merging associate Agribiotech Industries into the listed company, a scheme shareholders approved in October 2026. Its wholly-owned subsidiary, Solkit Distillery, commenced production in September 2026, strengthening the group's manufacturing capabilities.
What caused the spike in Agribio Spirits' revenue in the previous quarter (Q4 FY26)?
The research does not specify the exact cause for the ₹12.95 crore revenue in Q4 FY26. The volatile quarterly revenue trend suggests it may have been driven by a specific, non-recurring transaction or order in the legacy trading business.
What guidance did Agribio Spirits management provide?
No specific management guidance from a Q1 FY27 concall was found in the research. The available commentary focuses on the ongoing corporate restructuring and the operational start of the Solkit Distillery subsidiary post-quarter.
Have any brokerages changed their rating for Agribio Spirits?
Yes. MarketsMojo downgraded Agribio Spirits from 'Sell' to 'Strong Sell' on November 10, 2026. The rating agency cited deteriorating technical indicators, flat financial performance, and a lack of operating profitability as key reasons for the downgrade.
How did Agribio Spirits stock react to the Q1 FY27 results?
The stock's reaction to the August 14 results announcement is not detailed. However, the share price hit a 52-week high of ₹349.95 in November 2026, showing strong momentum despite the weak quarterly fundamentals, as noted by MarketsMojo.
What is the source of other income for Agribio Spirits?
The research does not specify the exact source of the ₹0.56 crore other income in Q1 FY27. For a company in transition, it typically includes items like interest income, dividend from investments, or gains on asset sales, which are not from core operations.
What are the risks for Agribio Spirits' new alcohol business?
Key risks include execution delays in merging Agribiotech Industries, regulatory approvals for the merger, and the challenge of scaling up new manufacturing operations at Solkit Distillery to generate sustainable revenue and replace the lost jute income.
Agribio Spirits Q1 FY27 results August 2026
Agribio Spirits announced its Q1 FY27 results for the June 2026 quarter on August 14, 2026. The company reported a net profit of ₹1.21 crore, up 23.5% year-on-year, while revenue from operations collapsed by 91.4% to ₹0.63 crore.
Agribio Spirits Q2 FY27 results board meeting
Agribio Spirits scheduled a board meeting for November 13, 2026, to consider and approve the unaudited financial results for Q2 FY27 (the July-September 2026 quarter). This follows the volatile Q1 results reported in August.